The newsetters are in PDF format and require Adobe Acrobat Reader to view. If you do not already have Acrobat Reader, you can download it here for free.
Need these files as accessible for the disabled? Visit http://access.adobe.com
Resident Research
Resident Research is a booklet of the research conducted by our residents each year.
Residents' Roar
Residents' Roar is a newsletter about our residents and the residency program.
Scientific Research: Publications by Current and Former Residents
This list represents self-reports and a search of the literature. We apologize for any inadvertent ommissions or oversights.
2009American College of Clinical Pharmacy, Blair MM, Freitag RT, Keller DL, Kiser TH, Marrs JC, McGivney MS, Mohammad RA, Twedt EL; ACCP Certification Affairs Committee. Proposed revision to the existing specialty and specialist certification framework for pharmacy practitioners. Pharmacotherapy. 2009;29(4):3e-13e.
Bellamy CJ, Kane-Gill SL, Falcione BA, Seybert AL. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol. J Trauma. 2009;66(3):954-8.
Campara M, Shord SS, Haaf CM. Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach. J Clin Pharm Ther. 2009;34(2):207-13.
Ceresia ML, Fasser CE, Rush JE et al. The role and education of the veterinary pharmacist. Am J Pharm Educ. 2009;73(1):16.
Chan EW, Taylor SE, Marriott JL, Barger B. Bringing patients' own medications into an emergency department by ambulance: effect on prescribing accuracy when these patients are admitted to hospital. Med J Aust. 2009;191(7):374-7.
Coons JC, Barnes M, Kusick K. Takotsubo cardiomyopathy. Am J Health Syst Pharm. 2009;66(6):562-6.
Desai D, Goldbach-Mansky R, Milner JD et al. Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs. Ann Pharmacother. 2009;43:967-972.
Donihi AC, Weber RJ, Sirio CA, Mark SM, Meyer SM. An advanced pharmacy practice experience in inpatient medication education. Am J Pharm Educ. 2009;73(1):11.
Drusano GL, Okusanya OO, Okusanya AO et al. Impact of spore biology on the rate of kill and suppression of resistance in Bacillus anthracis. Antimicrob Agents Chemother. 2009 Aug 17. [Epub ahead of print]
Egorin MJ, Shah DD, Christner SM, Yerk MA, Komazec KA, Appleman LR, Redner RL, Miller BM, Beumer JH. Effect of a proton pump inhibitor on the pharmacokinetics of imatinib. Br J Clin Pharmacol. 2009;68(3):370-4.
Felix-Getzik E, Sylvia LM. Vancomycin-induced leukocytoclastic vasculitis. Pharmacotherapy. 2009;29(7):846-51.
Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Physician. 2009;79(2):135-40.
Freeman MK, Lauderdale SA,Kendrach MG, Woolley TW. Google scholar versus PubMed in locating primary literature to answer drug-related questions . Ann Pharmacother. 2009;43(3):478-484.
Garcia GM, Snyder ME, McGrath SH, Smith RB, McGivney MS. Generating demand for pharmacist-provided medication therapy management: identifying patient-preferred marketing strategies. J Am Pharm Assoc (2003). 2009;49(5):611-6.
Gleason PP, Starner CI, Gunderson BW et al. Association of prescription abandonment with cost share for high-cost specialty pharmacy medications. J Manag Care Pharm. 2009;15(8):648-58.
Gortney JS, Fagan A, Kissack JC. Neuroleptic malignant syndrome secondary to quetiapine. Ann Pharmacother. 2009;43(4):785-91.
Hall DL, Corman SL, Drab SR, Meyer SM, Smith RB. Instructor satisfaction with a technology-based resource for diabetes education. Am J Pharm Educ. 2009;73(3):45.
Hansen RA, Chin H, Blalock S, Joy MS. Predialysis chronic kidney disease: evaluation of quality of life in clinic patients receiving comprehensive anemia care. Res Social Adm Pharm. 2009;5(2):143-53.
Havrilla PL, Kane-Gill SL, Verrico MM, Seybert AL, Reis SE. Coronary vasospasm and atrial fibrillation associated with ondansetron therapy. Ann Pharmacother. 2009;43:532-536.
Hung WY, Kogelman L, Volpe G, Iafrati M, Davidson L. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents. 2009;34:486-9.
Joy MS, Dornbrook-Lavender K, Blaisdell J et al. CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases. Eur J Clin Pharmacol. 2009;65(9):947-53.
Joy MS, Gipson DS, Dike M et al. Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group. Clin J Am Soc Nephrol. 2009;4(1):39-47.
Joy MS, Hilliard T, Hu Y et al. Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Pharmacother. 2009;43(6):1020-7.
Joy MS, Hilliard T, Hu Y et al. Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Pharmacotherapy. 2009;29(1):7-16.
Kane-Gill SL, Bellamy CJ, Verrico MM, Handler SM, Weber RJ. Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU). Pharmacoepidemiol Drug Saf. 2009. [Epub ahead of print]
Kearney BP, Mathias A. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives. Pharmacotherapy. 2009;29(8):924-9.
Kelley LR, Corman SL, Weber RJ. A pharmacy director’s primer on the American Recovery and Reinvestment Act of 2009. Hospital Pharmacy 2009;44:813-18.
Lyman GH, Lalla A, Barron RL, Dubois RW. Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States. Clin Ther. 2009;31(5):1092-104.
Mathias AA, West S, Hui J, Kearney BP. Dose-response of ritonavir on hepatic CYP3A activity and elvitegravir oral exposure. Clin Pharmacol Ther. 2009;85(1):64-70.
Momary KM, Shapiro NL, Brace LD, Shord SS, Grossi E, Viana MA, Helgason CM, Nutescu EA, Cavallari LH. Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke. Cerebrovasc Dis. 2009;27(6):585-93.
Naeger Murphy N, Pile JC. Clinical Indications for Newer Antifungal Agents. Journal of Hospital Medicine 2009;4:102-11.
Nathan JP, Gim S. Responding to drug information requests. Am J Health Syst Pharm. 2009;66 706-711.
Noschese ML, DiNardo MM, Donihi AC et al. Patient outcomes after implementation of a protocol for inpatient insulin pump therapy. Endocr Pract. 2009;15(5):415-24.
Okusanya OO, Bhavnani SM, Hammel J et al. Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection. Antimicrob Agents Chemother. 2009;53(9):3847-54.
Palkovic LB, Coley KC, Sokos DR. Factors associated with inappropriate inpatient prescribing of acid-suppressive therapy. International Journal of Pharmacy Practice 2009;17:73-75.
Patel GW, Patel N, Lat A et al. Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections. Diagn Microbiol Infect Dis. 2009;64(2):236-40.
Pogue JM, DePestel DD, Kaul DR et al. Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract. Transpl Infect Dis. 2009;11(5):467-70.
Sahi J, Shord SS, Lindley C, Ferguson S, LeCluyse EL. Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes. J Biochem Mol Toxicol. 2009;23(1):43-58.
Schafer JA, Kjesbo NK, Gleason PP. Critical review of prasugrel for formulary decision makers. J Manag Care Pharm. 2009;15(4):335-43.
Shields RK, Martello JL, Potoski BA. Is vancomycin ototoxicity a significant risk? Antimicrob Agents Chemother. 2009;53(10):4572.
Shord SS, Shah K, Lukose A. Drug--botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals. Integr Cancer Ther. 2009;8(3):208-27.
Shord SS, Patel SR. Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines. J Exp Clin Cancer Res. 2009;28:76.
Shord SS, Bressler LR, Tierney LA, Cuellar S, George A. Understanding and managing the possible adverse effects associated with bevacizumab. Am J Health Syst Pharm. 2009;66(11):999-1013.
Shord SS, Cavallari LH, Gao W, Jeong HY, Deyo K, Patel SR, Camp JR, Labott SM, Molokie RE. The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease. Eur J Clin Pharmacol. 2009;65(7):651-8.
Shrank WH, Gleason PP, Canning C, et al Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the target pharmacy label. J Gen Intern Med. 2009;24(5):570-8.
Shrank WH, Patrick A, Gleason PP et al. An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes. Med Care. 2009;47(9):1031-5.
Song X, Fowler R, Ruiz K, Hurley D, Barron RL. Impact of neutropenic complications on short-term disability in patients with cancer receiving chemotherapy. J Med Econ. 2009;12(2):154-63.
Starner CI, Norman SA, Reynolds RG, Gleason PP. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly. Am J Geriatr Pharmacother. 2009;7(1):11-9.
Suhrie EM, Hanlon JT, Jaffe EJ et al. Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing. Am J Geriatr Pharmacother. 2009;7(1):20-5.
Watson K, Summers KM. Depression in patients with heart failure: clinical implications and management. Pharmacotherapy. 2009;29(1):49-63.
Wisniewski CS, Pummer TL, Krenzelok EP. Documenting drug information questions using software for poison information documentation. Am J Health Syst Pharm. 2009;66 1039-1043.
Wong AK, Stephens SB, Aspinall MB, Visweswaran S, Hanlon JT, Handler SM. Assessing the quality of prescribing and monitoring erythropoiesis-stimulating agents in the nursing home setting. J Am Med Dir Assoc. 2009;10(6):436-9.
Yeoh BS, Taylor DM, Taylor SE. Education initiative improves the evidence-based use of metoclopramide following morphine administration in the emergency department. Emerg Med Australas. 2009;21(3):178-83.
Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J, Drusano GL. Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis. Diagn Microbiol Infect Dis. 2008;61(1):13-20.
Barkell M. Bleeding associated with warfarin use: improving outcomes. Arch Intern Med. 2008;168(2):236-7. Letter.
Bliden KP, DiChiara J, Lawal L, Singla A, Antonino MJ, Baker BA, Bailey WL, Tantry US, Gurbel PA. The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel. J Am Coll Cardiol 2008;52:531-3.
Coons JC, Battistone S. 2007 guideline update for unstable angina/ non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies. Ann Pharmacother 2008;42:989-1001.
Dauner DG, Deremer CE, Haburchak D. Clozapine-induced pericardial effusion. J Clin Psychopharmacol. 2008;28(4):455-6. Letter.
DeRemer CE. Vanlandingham J. Carswell J. Killough D. Pharmacy Outreach Education Program in Local Community. [letter]. American Journal of Pharmaceutical Education 2008;72(4) Article 94:1.
Donihi AC, Yang E, Mark SM, Sirio CA, Weber RJ. Scheduling of pharmacist-provided medication education for hospitalized patients. Hosp Pharm. 2008;43:121-126.
Drusano GL, Okusanya OO, Okusanya A et al. Is 60 days of ciprofloxacin administration necessary for postexposure prophylaxis for Bacillus anthracis? Antimicrob Agents Chemother. 2008;52(11):3973-9.
Elion R, Cohen C, Ward D, Ruane P, Ortiz R, Reddy YS, Ebrahimi R, McColl D, Kearney B, Fisher A, Flaherty J. BATON Study Group. Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naive patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily. HIV Clin Trials. 2008;9(4):213-24.
Ference JD, Medina MS. Modifying a traditional course for the PharmD curriculum. Am J Pharm Educ. 2008;72(5):122.
Gilreath JA, Sageser DS, Jorgenson JA, Rodgers GM. Establishing an anemia clinic for optimal erythropoietic-stimulating agent use in hematology-oncology patients. J Natl Compr Canc Netw. 2008;6(6):577-84.
Harris IM, Baker E, Berry TM, Halloran MA, Lindauer K, Ragucci KR, McGivney MS, Taylor AT, Haines ST. Developing a business-practice model for pharmacy services in ambulatory settings. Pharmacotherapy. 2008;28(2):285.
Israeli RS, Ryan CW, Jung LL. Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy. J Urol. 2008;179(2):414-23.
Johnson JL, McCarthy MW. Enteral administration of three proton-pump-inhibitor formulations. Am J Health-Syst Pharm. 2008;65(24):2324-5.
Jones KE, Puccio AM, Harshman KJ, Falcione B, Benedict N et al. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus. 2008;25(4):E3.
Joy MS, Dornbrook-Lavender KA, Chin H et al. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients. Ann Pharmacother. 2008;42(1):9-15.
Lewis NJ, Bugdalski-Stutrud C, Abate MA, Blommel M, Wu CH, Gaither CA. The Medication Assessment Program: comprehensive medication assessments for persons taking multiple medications for chronic diseases. J Am Pharm Assoc. 2008;48(2):171-80.
Lionaki S, Hogan SL, Falk RJ, Joy MS, Jennette CE, Nachman PH, Jennette JC. Vasculitis and anti-thyroid medication. Nephrol Dial Transplant. 2008;23(5):1766-8. Letter.
Mathias AA, Hinkle J, Shen G, Enejosa J, Piliero PJ, Sekar V, Mack R, Tomaka F, Kearney BP. Effect of ritonavir-boosted tipranavir or darunavir on the steady-state pharmacokinetics of elvitegravir. J Acquir Immune Defic Syndr. 2008;49(2):156-62.
Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2008;65(3):396-406.
Nkansah NT, Brewer JM, Connors R, Shermock KM. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice. Am J Health-Syst Pharm. 2008;65(2):145-9.
Noschese M, Donihi AC, Koerbel G et al. Effect of a diabetes order set on glycaemic management and control in the hospital. Qual Saf Health Care. 2008;17(6):464-8.
Ramanathan S, Kakuda TN, Mack R, West S, Kearney BP. Pharmacokinetics of elvitegravir and etravirine following coadministration of ritonavir-boosted elvitegravir and etravirine. Antivir Ther. 2008;13(8):1011-7.
Rea RS, Capitano B, Bies R et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit. 2008;30(6):674-81.
Refaat M, McNamara D, Teuteberg J, Kormos R, McCurry K, Shullo M, Toyoda Y, Bermudez C. Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia. J Heart Lung Transplant. 2008;27(6):699-700. Letter.
Schwartz RN, Vozniak M. Current and emerging treatments for multiple myeloma. J Manag Care Pharm. 2008;14(7 Suppl):12-9.
Sevene E, Mariano A, Mehta U et al. Spontaneous adverse drug reaction reporting in rural districts of Mozambique. Drug Saf. 2008;31(10):867-76.
Shermock KM, Horn E, Rice TL. Erythropoietic agents for anemia of critical illness. Am J Health-Syst Pharm. 2008;65(6):540-6.
Shord SS, Bressler LR, Radhakrishnan L, Chen N, Villano JL. Evaluation of the Modified Diet in Renal Disease equation for calculation of carboplatin dose. Ann Pharmacother. 2009;43(2):235-41.
Shord SS, Cavallari LH, Viana MA, Momary K, Neceskas J, Molokie RE, Deyo K, Patel SR. HYPERLINK "http://preview.ncbi.nlm.nih.gov/pubmed/18793590?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=10" Cytochrome P450 2C9 mediated metabolism in people with and without cancer. Int J Clin Pharmacol Ther. 2008;46(7):365-74.
Shord SS, Chew L, Villano J. Evaluation of opioid induced nausea and vomiting in sickle cell disease. Am J Hematol. 2008;83(3):196-9.
Shord SS, Cuellar S. Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation. J Am Pharm Assoc (2003). 2008;48(4):487-93.
Shord SS, Hamilton JM Jr, Cuellar S. Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia. J Oncol Pharm Pract. 2008;14(1):5-22.
Snyder CM, Helms BE, Hall DL. Evaluation of INR Monitoring Frequency and Time in Therapeutic Range. J Pharm Technol. 2008;24:255-60.
Starner C, Schafer S, Heaton AH, Gleason PP. Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated with Five Risk-Warning Events. Journal of Managed Care Pharmacy2008;14(6):523-31.
Starner C, Gleason PP. Cholinesterase Inhibitor Utilization Patterns: Just Because It Can Be Counted Does Not Mean It Counts. Journal of Managed Care Pharmacy 2008;14(5):462-464.
Sweiss KI, Beri R, Shord SS. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature. Drug Saf. 2008;31(11):989-96.
Tobia CC, Aspinall SL, Good CB, Fine MJ, Hanlon JT. Appropriateness of antibiotic prescribing in veterans with community-acquired pneumonia, sinusitis, or acute exacerbations of chronic bronchitis: a cross-sectional study. Clin Therap. 2008;30(6):1135-44.
Tomlinson D, Isitt JJ, Barron RL et al. Determining the understandability and acceptability of an oral mucositis daily questionnaire. J Pediatr Oncol Nurs. 2008;25(2):107-11
Van Rompay KK, Durand-Gasselin L, Brignolo LL, Ray AS, Abel K, Cihlar T, Spinner A, Jerome C, Moore J, Kearney BP, Marthas ML, Reiser H, Bischofberger N. Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects. Antimicrob Agents Chemother. 2008;52(9):3144-60.
Vila T, Gommer J, Scates AC. Role of gabapentin in the treatment of uremic pruritus. Ann Pharmacother. 2008;42(7):1080-4.
Vourvahis M, Tappouni HL, Patterson KB, Chen YC, Rezk NL, Fiscus SA, Kearney BP, Rooney JF, Hui J, Cohen MS, Kashuba AD. The pharmacokinetics and viral activity of tenofovir in the male genital tract. J Acquir Immune Defic Syndr. 2008;47(3):329-33.
Walbrown MA, Aspinall SL, Bayliss NK, Stone RA, Cunningham F, Squier CL, Good CB. Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones. J Manag Care Pharm. 2008;14(1):34-40.
Abate MA, Blommel ML. A self-assessment tool for drug information advanced pharmacy practice experience. Am J Pharm Education 2007; 71(1): Article 02.
Benedict N, Seybert A, Mathier M, MD. Evidence-Based Pharmacologic Management of Pulmonary Arterial Hypertension. Clinical Therapeutics. 2007;29(10):2134-2153.
Benedict NJ. Sitaxsentan in the management of pulmonary arterial hypertension. Am J Health Syst Pharm 2007;64:363-368.
Coons JC, Fera T. Multidisciplinary team for enhancing care for patients with acute myocardial infarction or heart failure. Am J Health Syst Pharm 2007;64:1274-1278.
Coons JC, Seidl E. Cardiovascular pharmacotherapy update for the intensive care unit. Crit Care Nurs Q. 2007 Jan-Mar;30(1):44-57.
Corman SL, Skledar SJ, Culley CM. Evaluation of conflicting literature and application to formulary decisions. Am J Health-Syst Pharm 2007;64:182-185.
Corman SL, Skledar SJ. Use of lipid emulsion to reverse local anesthetic-induced toxicity. Ann Pharmacother. 2007;41(11):1873-7.
Deremer CE, Ford H, Lee Y. Lifestyle characteristics of medical center employees. Am J Health-Syst Pharm. 2007;64(19):2000-1. Letter.
Gleason PP, Shaughnessy AF. Telithromycin (Ketek) for Community Acquired Pneumonia. American Family Physician 2007;76:1857-8.
Gleason PP, Walters C, Heaton AH, Schafer JA. Telithromycin: the perils of hasty adoption and persistence of off-label prescribing. J Manag Care Pharm. 2007 Jun;13(5):420-5.
Gleason PP. Assessing step-therapy programs: a step in the right direction. J Manag Care Pharm. 2007 Apr;13(3):273-5.
Gortney JS, Sanders RM. Impact of C-reactive protein on treatment of patients with cardiovascular disease. Am J Health-Syst Pharm. 2007;64(19):2009-16.
Joy MS, Candiani C, Vaillancourt BA, Chin H, Hogan SL, Falk RJ. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease. Pharmacotherapy. 2007 May;27(5):734-44.
Joy MS, Hogan SL, Thompson BD, Finn WF, Nickeleit V. Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity. Nephrol Dial Transplant. 2007 Jul;22(7):1963-8. Epub 2007 Mar 29.
Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm. 2007 Jun;13(5):397-411.
Juang P, Fish DN, Jung R, Maclaren R. Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evaluation. Pharmacotherapy. 2007;27(1):11-9.
Juang P, Skledar SJ, Zgheib NK, Paterson DL, Vergis EN, Shannon WD, Ansani NT, Branch RA. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. Am J Infect Control. 2007;35(2):131-7.
Juang P. Update on new antifungal therapy. AACN Adv Crit Care. 2007;18(3):253-60.
Kane-Gill SL, Olsen KM, Rebuck JA, Rea RS, Boatwright DW, Smythe MA et al. Aspiration Evaluation Group of the Clinical Pharmacy and Pharmacology Section. Multicenter treatment and outcome evaluation of aspiration syndromes in critically ill patients. Ann Pharmacother. 2007;41(4):549-55.
Kockler DR, McCarthy MW. Zoster vaccine live. Pharmacotherapy. 2007 Jul;27(7):1013-9.
Kunze AM, Gunderson BW, Gleason PP, Heaton AH, Johnson SV. Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs--pharmacy and medical benefit spending from 2004 through 2007. J Manag Care Pharm. 2007;13(9):799-806.
Lauderdale SA, Kendrach MG, Freeman MK. Preparing students for community pharmacy practice during a drug information advanced practice experience. Am J Pharm Educ. 2007;71(2):25.
Lauderdale SA, Kendrach MG, Freeman MK. Preparing students for community pharmacy practice during a drug information advanced practice experience. Am J Pharm Educ. 2007 Apr 15;71(2):25.
Lionaki S, Hogan SL, Falk RJ, Joy MS, Chin H, Jennette CE, Jennette JC, Nachman PH. Association of thyroid disease and its treatment with ANCA small-vessel vasculitis: a case control study. Nephrol Dial Transplant. 2007 Aug 8; [Epub ahead of print]
Mathias AA, Hinkle J, Menning M, Hui J, Kaul S, Kearney BP. Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen Development Team. Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. J Acquir Immune Defic Syndr. 2007;46(2):167-73.
McGivney MS, Meyer SM, Duncan-Hewitt W et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc. 2007;47(5):620-8.
McMillen K, Weber RJ. Developing patient-centered pharmacy services through residency training. Hosp Pharm. 2007;42(8):756-759.
Mehta U, Durrheim D, Mabuza A et al. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa. Drug Saf. 2007;30(10):899-910.
Mehta U, Maartens G. Is it safe to switch between efavirenz and nevirapine in the event of toxicity? Lancet Infect Dis. 2007;7(11):733-8.
Noronha G, Miller J, Brewer JM. Pharmacists as nonphysician practitioners. Fam Pract Manag. 2007 Jan;14(1):11.
Okusanya O, Forrest A, DiFrancesco R, Bilic S, Rosenkranz S, Para MF, Adams E, Yarasheski KE, Reichman RC, Morse GD; ACTG 5043 Protocol Team. Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks. Antimicrob Agents Chemother. 2007 May;51(5):1822-6. Epub 2007 Feb 5.
Pogue JM, Paterson DL, Pasculle AW, Potoski BA. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol. 2007;28(12):1382-8.
Ramanathan S, Shen G, Cheng A, Kearney BP. Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137. J Acquir Immune Defic Syndr. 2007;45(3):274-9.
Ramanathan S, Shen G, Hinkle J, Enejosa J, Kearney BP. Pharmacokinetics of coadministered ritonavir-boosted elvitegravir and zidovudine, didanosine, stavudine, or abacavir. J Acquir Immune Defic Syndr. 2007;46(2):160-6.
Rea RS, Battistone S, Fong JJ, Devlin JW. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy. 2007 Apr;27(4):588-94.
Rea RS, Capitano B. Optimizing use of aminoglycosides in the critically ill. Semin Respir Crit Care Med. 2007;28(6):596-603.
Rea RS, Donihi AC, Bobeck M, Herout P, McKaveney TP, Kane-Gill SL, Korytkowski MT. Implementing an intravenous insulin infusion protocol in the intensive care unit. Am J Health Syst Pharm. 2007 Feb 15;64(4):385-95.
Shabsigh R, Duval S, Shah M, Regan TS, Juhasz M, Veltry LG. Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data. Curr Med Res Opin. 2007;23(10):2453-60.
Skledar SJ, McKaveney TP, Sokos DR, Ervin KA, Coldren M, Hynicka L, Lavsa S, Reynolds R, Beauchamp R. Role of student pharmacist interns in hospital-based standing orders pneumococcal vaccination program. J Am Pharm Assoc. 2007;47(3):404-9.
Somma MA, Meyer SM. “Community of Learning” in experiential education. Am J Pharm Educ 2007;71(1): Article 19.
Szczesiul JM, Shermock KM, Murtaza UI, Siberry GK. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections. Pediatr Infect Dis J. 2007;26(9):852-4.
Taylor SE, Braitberg G, Lugt J. Multifaceted education initiative minimizes pethidine prescribing in the emergency department. Emerg Med Australas. 2007 Feb;19(1):25-30.
Watson K, Seybert AL, Saul MI, Lee JS, Kane-Gill SL. Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention. Pharmacotherapy. 2007;27(5):647-656.
Zhang D, Carlson AM, Gleason PP et al. Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers. J Manag Care Pharm. 2007;13(8):664-76.
Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes. Clin Ther. 2007;29(1): p 74-83. 2007.
